The Wistar Institute
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1972-01-01
- Employees
- 501
- Market Cap
- -
- Website
- http://www.wistar.org
Reducing Proviral HIV DNA With Interferon-a
- First Posted Date
- 2014-08-28
- Last Posted Date
- 2018-04-05
- Lead Sponsor
- The Wistar Institute
- Target Recruit Count
- 54
- Registration Number
- NCT02227277
- Locations
- 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸Jonathan Lax Center at Philadelphia FIGHT, Philadelphia, Pennsylvania, United States
🇺🇸Penn-Presbyterian Hospital, Philadelphia, Pennsylvania, United States
Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV
- First Posted Date
- 2013-09-04
- Last Posted Date
- 2023-07-06
- Lead Sponsor
- The Wistar Institute
- Target Recruit Count
- 20
- Registration Number
- NCT01935089
- Locations
- 🇺🇸
AIDS Clinical Trials Unit (ACTU), and Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States
🇺🇸Jonathan Lax Clinic, Philadelphia FIGHT, Philadelphia, Pennsylvania, United States
🇺🇸Presbyterian Hospital, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States
Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection
- Conditions
- Interventions
- First Posted Date
- 2008-01-16
- Last Posted Date
- 2015-02-10
- Lead Sponsor
- The Wistar Institute
- Target Recruit Count
- 23
- Registration Number
- NCT00594880
- Locations
- 🇺🇸
Drexel University College of Medicine, Philadelphia, Pennsylvania, United States
🇺🇸Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸Jonathan Lax Immune Disorders Clinic, Philadelphia, Pennsylvania, United States
Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa
- Conditions
- Interventions
- First Posted Date
- 2005-01-05
- Last Posted Date
- 2014-08-27
- Lead Sponsor
- The Wistar Institute
- Target Recruit Count
- 30
- Registration Number
- NCT00100646
- Locations
- 🇿🇦
University of the Witwatersrand, Johannesburg, South Africa
Immune and Viral Outcomes of HIV-1 Therapy Interruption
- Conditions
- First Posted Date
- 2003-01-24
- Last Posted Date
- 2016-02-09
- Lead Sponsor
- The Wistar Institute
- Target Recruit Count
- 20
- Registration Number
- NCT00051818
- Locations
- 🇺🇸
The Wistar Institute, Philadelphia, Pennsylvania, United States